Cargando…
Efficacy of Dupilumab in severe Atopic Dermatitis (AD) using the AD Control Tool (ADCT) Score in the population of Qatar
Atopic Dermatitis (AD) is a high-burden disease that affects approximately 2–5% of adults. AD patients experience intense pruritus and often report sleep and mental health disturbances accompanied by a diminished quality of life. The patients’ perceptions of their treatment benefits are becoming inc...
Autores principales: | Joy, Febu, AlKhawaga, Sara, Iqneibi, Maryam, Marri, Fahad Al, Chalabi, Radi Al, Buddenkotte, Joerg, Steinhoff, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
HBKU Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660452/ https://www.ncbi.nlm.nih.gov/pubmed/38025319 http://dx.doi.org/10.5339/qmj.2023.sqac.11 |
Ejemplares similares
-
Epidemiology of Geriatric-Dermatology virtual clinic: Teledermatology-Based care for elderly patients with skin diseases in Qatar
por: Al-Khawaga, Sara, et al.
Publicado: (2023) -
Aeroallergens sensitization pattern in atopic patients in Qatar: A retrospective study
por: Thalappil, Sherin, et al.
Publicado: (2023) -
The Second Qatar Allergy and Immunology Conference: An Editorial
por: Ali AL-Nesf, Maryam, et al.
Publicado: (2023) -
Subcutaneous immunoglobulin therapy for adult patients with primary immunodeficiency disease: Qatar experience
por: Thalappil, Sherin, et al.
Publicado: (2023) -
The rate of exacerbations in patients with asthma in Qatar: A retrospective study during 2019-2021
por: Isaifan, Dina, et al.
Publicado: (2023)